ArticleAntiviral chemistry & chemotherapy

V3-Loop genotypes do not predict maraviroc susceptibility of CCR5-tropic virus or clinical response through week 48 in HIV-1-infected, treatment-experienced persons receiving optimized background regimens.

M E Lewis et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.